Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALStandard

ESTRING

ESTRADIOL

Standard Dose
0.0075MG/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ESTRING is listed in Drugs@FDA under application 020472 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR Sponsor PFIZER Submission history Latest submission status date: 2026-02-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESTRING is listed in Drugs@FDA under application 020472 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESTRADIOL Form and strength INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR Sponsor PFIZER Submission history Latest submission status date: 2026-02-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.